Michelle D. James

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 967 citations

Medicine, Oncology, Pharmacology +12

Efficient Estimation Methods for "Closed-Ended" Contingent Valuation Surveys

Trudy Ann Cameron, Michelle D. James · The Review of Economics and Statistics · 1987 · 622 citations

Natural Resources, Economics, Fisheries +17

Estimating Willingness to Pay from Survey Data: An Alternative Pre-Test-Market Evaluation Procedure

Trudy Ann Cameron, Michelle D. James · Journal of Marketing Research · 1987 · 195 citations

Social Sciences, Business Economics, Economics +13

Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab

Christopher G. Smith, David J. Fisher, Bart Claes et al. · Clinical Cancer Research · 2013 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Estimating Willingness to Pay from Survey Data: An Alternative Pre-Test-Market Evaluation Procedure

Trudy Ann Cameron, Michelle D. James · Journal of Marketing Research · 1987 · 76 citations

Social Sciences, Business Economics, Economics +13